TB Research

Mycotic infrarenal aortic aneurysm due to mycobacterium after intravesical treatment for bladder cancer

Steve Thanh D. Pham, Ashton Lee, Janin S. Struminger, Kenneth M. Belkoff, Bernardo Mendoza, Scott S. Berman

Journal of Vascular Surgery Cases and Innovative Techniques · 2021-03

Abstract

, is a common adjuvant therapy for bladder cancer with a low incidence of serious adverse events. The case described herein illustrates a rare complication of intravesical Bacillus Calmette-Guerin instillation that resulted from invasion of the mycobacterium into tissue outside of the bladder lining, also known as microbial dissemination, leading to infection of the aortic wall and development of a mycotic aneurysm, and highlights the therapeutic challenges presented by the aortic pathology in this clinical scenario.

MeSH terms

  • Medicine
  • Bladder cancer
  • Mycobacterium bovis
  • Adjuvant
  • Aortic aneurysm
  • Complication
  • Surgery
  • Mycotic aneurysm
  • Mycobacterium
  • Urology
  • Cancer